(E) CD83 expression by LPS-stimulated BM-DC generated from CD83 Ϫ/Ϫ and wild-type (CD83 ϩ/ϩ ) littermates. RNA was reverse transcribed and PCR amplified using primers within the 5Ј and 3Ј untranslated regions (internal to the Hinc II site in exon 5), which generated a 660 bp fragment when full-length CD83 transcripts were present. Actin was amplified as a control. Results in (D) and (E) represent three littermate pairs.
tor replaced parts of exons 3-5 with a neomycin resislittermates. Although DN and DP thymocyte numbers were generally normal, CD83 Ϫ/Ϫ littermates had a 68% tance gene that introduced upstream stop codons within CD83 transcripts ( Figures 1A-1C) . The deleted reduction in CD4 ϩ SP thymocyte numbers (Figure 2A ϩ/Ϫ mice ( Figure 1D ). Overall, CD8 ϩ SP thymocytes did not increase in CD83 Ϫ/Ϫ mice, although numbers varied slightly beBone marrow-derived dendritic cells (BM-DC) from CD83 Ϫ/Ϫ mice failed to produce full-length CD83 trantween mice (Figure 2A ). The phenotype of CD83 Ϫ/Ϫ mice did not result from altered cell surface CD4 density, scripts, which were easily detected in wild-type BM-DC ( Figure 1E ). CD83 Ϫ/Ϫ mice were produced at the since DP thymocytes and CD4 ϩ T cells expressed wildtype levels of CD4 (Figures 2A and 2B Figure 4B ). An antisense CD83 probe did not hybridize with tissues in CD83 Ϫ/Ϫ mice CD8 ϩ T cell numbers in CD83 Ϫ/Ϫ mice ( Figure 2 ) and suggests that CD83 expression may promote CD4 sig-( Figure 4B ). Sense probes did not hybridize in wild-type and CD83 Ϫ/Ϫ mouse tissues. Purified thymic epithelial nals in DP thymocytes. Although circulating CD8 ϩ T cell numbers were significantly increased in CD83 Ϫ/Ϫ AND cells (CD45 Ϫ CD205 ϩ CD11c Ϫ ) and DC (CD205 ϩ CD11c ϩ ) expressed CD83 transcripts at similar levels, while DP littermates, CD8 ϩ T cell numbers within the spleen and lymph nodes were normal. thymocytes did not express detectable CD83 transcripts ( Figure 4C ). CD83 transcripts were expressed at Ͼ100-Impaired CD4
ϩ SP thymocyte and T cell development in CD83
Ϫ/Ϫ mice were stable phenotypic characteristics. fold higher levels by BM-DC than total thymus tissue or purified splenic T cells and B cells ( Figure 4D ). Thus, CD83
Ϫ/Ϫ mice crossed with C57BL/6 mice for four generations maintained the striking phenotypic characterismouse CD83 was expressed by both thymic DC and epithelial cells, in contrast to human thymus, where DC tics of CD83 Ϫ/Ϫ founder mice. This was also true for all CD83 Ϫ/Ϫ AND ϩ littermates. Moreover, CD83 Ϫ/Ϫ genopredominantly express CD83 (Zhou et al., 1992). To assess whether CD83 on thymic DC or epithelial types and phenotypes remained 100% concordant, suggesting that the phenotype of CD83 Ϫ/Ϫ mice resulted cells was required for CD4 ϩ T cell development, purified thymic or splenic DCs or cultured fetal thymic epithelial from selective gene targeting rather than genetic alterations independent of the CD83 locus. cells were transferred into the thymi of CD83 Ϫ/Ϫ mice. Figure 5A , Reflecting a significant decrease in the number of CD4 ϩ T cells exiting the thymus, the number of bromo- Table 1 ). In addition, the V␣11 ϩ T cells expressed V␣11, CD5, and CD3 at wild-type densities. By contrast, V␣11 Figures 3A-3C ).
Despite the dramatic effects of CD83 deficiency on II expression levels by blood and tissue monocytes from CD83
Ϫ/Ϫ mice were wild-type. Therefore, CD83 defi-CD4 ϩ DP thymocyte development, CD8 ϩ T cell development and numbers were generally normal (Figure 2 ). ciency significantly affected the activation status of peripheral B cells and inhibited antigen-specific humoral Blocked CD4 ϩ T cell development resulted from an in- Table 1 ). Moreover, CD4 ϩ T cells from CD83 Ϫ/Ϫ mice termates (Table 1) . Nonetheless, CD83 Ϫ/Ϫ and wild-type DCs generated equivalent levels of T cell proliferation proliferated normally in response to mitogens and during MLR assays (Figures 6C-6E) . Nonetheless, peripheral in allogeneic and syngeneic MLR assays ( Figure 6B) , and serum immunoglobulin levels were normal in CD4 ϩ and CD8 ϩ T cells in CD83 Ϫ/Ϫ mice expressed TCR, CD3, and CD5 at low levels ( Figure 2D ). In fact, CD4 in the thymus; signaled CD4 ϩ CD8 ϩ thymocytes initially terminate
